Table 4.

Multivariable Regression Results for Predicting LDL Cholesterol Control in 2010, by Baseline Patient Control Status

		Black Race, OR (95% CI)	No LLD at baseline OR (95% CI)	Regimen Increased, OR (95% CI)	Regimen Decreased, OR (95% CI)
Uncontrolled in 2008	Model A	0.53 (0.36 – 0.78)
	Model B	0.52 (0.35 – 0.76)	0.59 (0.39 – 0.89)	1.60 (1.03 – 2.50)	0.53 (0.28 – 0.99)
	Model C	0.52 (0.34 – 0.80)	0.67 (0.43 – 1.05)	1.59 (1.01 – 2.53)	0.62 (0.32 – 1.22)
Controlled in 2008	Model A	0.47 (0.32 – 0.69)
	Model B	0.49 (0.34 – 0.73)	0.56 (0.33 – 0.96)	1.13 (0.66 – 1.94)	0.39 (0.23 – 0.65)
	Model C	0.46 (0.30 – 0.70)	0.54 (0.31 – 0.96)	1.11 (0.62 – 1.98)	0.42 (0.24 – 0.72)

Model A: unadjusted

Model B: adjusted for lipid-lowering drug (LLD) at baseline and changes in treatment. Regimen increased includes addition of any LLD or increase in dosage of current LLD. Regimen decreased includes removal of any LLD or decrease in dosage of current LLD.

Model C: adjusted for variables in model B and patient characteristics (gender, age, neighborhood education, ischemic vascular disease, Dartmouth Atlas comorbidities, number of general medicine visits, insurance status)